Skip to main content
INCIDENCE AND RELEVANCE OF PROTEINURIA IN BEVACIZUMAB (BV)-TREATED PATIENTS (PTS): POOLED ANALYSIS FROM RANDOMIZED CONTROLLED TRIALS (RCTS) 37th Congress of the European-Society-for-Medical-Oncology (ESMO) Lafayette, R., McCall, B., Li, N. F., Chu, L., Werner, P., Das, A., Glassock, R. J. OXFORD UNIV PRESS. 2012: 171–171

View details for Web of Science ID 000309409000491